Exponent Inc. (NASDAQ:EXPO)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $59.36 and last traded at $59.36, with a volume of 42,903 shares. The stock had previously closed at $58.96.

Several brokerages have recently weighed in on EXPO. Avondale Partners began coverage on shares of Exponent in a research note on Thursday, July 7th. They set a “market perform” rating and a $60.00 price target for the company. Zacks Investment Research raised shares of Exponent from a “hold” rating to a “buy” rating and set a $57.00 price target for the company in a research note on Friday, April 22nd.

The firm has a 50-day moving average of $55.94 and a 200 day moving average of $50.69. The firm has a market capitalization of $1.54 billion and a P/E ratio of 33.28.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Wednesday, April 20th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.05. The firm had revenue of $79 million for the quarter, compared to analysts’ expectations of $77.15 million. During the same period in the prior year, the company earned $0.75 EPS. The firm’s quarterly revenue was up 3.8% on a year-over-year basis. Equities analysts predict that Exponent Inc. will post $1.84 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, June 24th. Stockholders of record on Friday, June 10th were given a dividend of $0.18 per share. The ex-dividend date was Wednesday, June 8th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.22%.

In other news, Director Stephen C. Riggins sold 3,200 shares of the company’s stock in a transaction on Monday, April 25th. The stock was sold at an average price of $49.32, for a total transaction of $157,824.00. Following the transaction, the director now owns 2,650 shares of the company’s stock, valued at approximately $130,698. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Paul R. Johnston sold 5,578 shares of the company’s stock in a transaction on Friday, July 8th. The shares were sold at an average price of $58.15, for a total value of $324,360.70. Following the transaction, the chief executive officer now directly owns 64,458 shares in the company, valued at approximately $3,748,232.70. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have recently modified their holdings of the stock. California State Teachers Retirement System boosted its position in shares of Exponent by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 48,123 shares of the company’s stock worth $2,404,000 after buying an additional 770 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of Exponent by 74.9% in the fourth quarter. First Trust Advisors LP now owns 26,087 shares of the company’s stock worth $1,303,000 after buying an additional 11,171 shares during the period. Rhumbline Advisers boosted its stake in shares of Exponent by 6.3% in the fourth quarter. Rhumbline Advisers now owns 33,165 shares of the company’s stock worth $1,657,000 after buying an additional 1,980 shares during the period. California Public Employees Retirement System boosted its stake in shares of Exponent by 11.6% in the fourth quarter. California Public Employees Retirement System now owns 106,400 shares of the company’s stock worth $5,315,000 after buying an additional 11,100 shares during the period. Finally, Comerica Bank boosted its stake in shares of Exponent by 0.7% in the fourth quarter. Comerica Bank now owns 27,900 shares of the company’s stock worth $1,322,000 after buying an additional 203 shares during the period.

Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.